Risk factors
Ainos (AIMD) risk factors
Item 1A of every Ainos, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors50 risks11 new2 reworded
Financial losses grew significantly with cumulative losses reaching $67.5 million in 2025 alongside continuing operating losses of $14.0 million. Revenue generation transitioned toward AI Nose related products while older revenue streams like COVID-19 tests dropped off. The risk profile expanded heavily around the commercialization, accuracy, and infrastructure dependencies of the AI Nose scent digitization platform.
Filed Mar 30, 2026 - FY2024 10-K risk factors39 risks
Ainos relies heavily on external capital and product development success for its VELDONA and POCT candidates.
Filed Mar 07, 2025